Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1981 1
1989 1
1995 1
2000 2
2003 1
2004 2
2005 1
2007 1
2015 2
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
Akinci G, Akinci B. Akinci G, et al. Recent Pat Endocr Metab Immune Drug Discov. 2015;9(2):74-8. doi: 10.2174/1574892811666151111142554. Recent Pat Endocr Metab Immune Drug Discov. 2015. PMID: 26556498 Review.
Metreleptin treatment has been demonstrated to improve metabolic abnormalities such as hyperglycemia, hypertriglyceridemia, increased hepatic fat content and elevated liver enzymes alanine transaminase and aspartate transaminase in patients with generalized l …
Metreleptin treatment has been demonstrated to improve metabolic abnormalities such as hyperglycemia, hypertriglyceridemia, increased hepati …
Molecular aetiology of primary hyperoxaluria and its implications for clinical management.
Danpure CJ, Rumsby G. Danpure CJ, et al. Expert Rev Mol Med. 2004 Jan 9;6(1):1-16. doi: 10.1017/S1462399404007203. Expert Rev Mol Med. 2004. PMID: 14987413 Review.
The primary hyperoxalurias type 1 (PH1) and type 2 (PH2) are autosomal recessive calcium oxalate kidney stone diseases caused by deficiencies of the metabolic enzymes alanine:glyoxylate aminotransferase (AGT) and glyoxylate/hydroxypyruvate reductase (GR/HPR), …
The primary hyperoxalurias type 1 (PH1) and type 2 (PH2) are autosomal recessive calcium oxalate kidney stone diseases caused by d …
Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients.
Winrich EJ, Gala KS, Rajhans A, Rios-Perez CD, Royer AJ, Zamani Z, Parthasarathy R, Marsano-Obando LS, Barve AJ, Schwandt ML, Vatsalya V. Winrich EJ, et al. Int J Mol Sci. 2022 Sep 26;23(19):11332. doi: 10.3390/ijms231911332. Int J Mol Sci. 2022. PMID: 36232646 Free PMC article.
Patients were grouped by serum alanine aminotransferase (ALT) level (a marker of liver injury) as group 1 (Group 1 (Gr.1); ALT 40 U/L, 7M/8F, without any indication of early-stage ALD) and group 2 (Group 2 (Gr.2); ALT > 40 U/L, 27M/6F or early-stage …
Patients were grouped by serum alanine aminotransferase (ALT) level (a marker of liver injury) as group 1 (Group 1 (Gr.1); ALT 40 U/L …
Efficacy and adverse reaction to different doses of atorvastatin in the treatment of type II diabetes mellitus.
Jiang H, Zheng H. Jiang H, et al. Biosci Rep. 2019 Jul 5;39(7):BSR20182371. doi: 10.1042/BSR20182371. Print 2019 Jul 31. Biosci Rep. 2019. PMID: 31189741 Free PMC article.
Background: Type II diabetes mellitus (T2DM), a persistent metabolic disorder, is primarily characterized by insulin resistance, relative insulin deficiency and dyslipidemia. Here, we aimed to investigate whether different doses of atorvastatin (ATV) affect rats with T2DM. …
Background: Type II diabetes mellitus (T2DM), a persistent metabolic disorder, is primarily characterized by insulin resistance, relative in …
Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype.
Coulter-Mackie MB. Coulter-Mackie MB. Am J Nephrol. 2005 May-Jun;25(3):264-8. doi: 10.1159/000086356. Epub 2005 Jun 15. Am J Nephrol. 2005. PMID: 15961945
BACKGROUND: Primary hyperoxaluria type 1 (PH1) is caused by a deficiency of peroxisomal alanine:glyoxylate aminotransferase (AGT). ...METHODS: The published data on mutations in the AGT gene were examined with respect to recurrences and geographic or ethnic associat …
BACKGROUND: Primary hyperoxaluria type 1 (PH1) is caused by a deficiency of peroxisomal alanine:glyoxylate aminotransferase (A …
Fetal liver alanine: glyoxylate aminotransferase and the prenatal diagnosis of primary hyperoxaluria type 1.
Danpure CJ, Jennings PR, Penketh RJ, Wise PJ, Cooper PJ, Rodeck CH. Danpure CJ, et al. Prenat Diagn. 1989 Apr;9(4):271-81. doi: 10.1002/pd.1970090406. Prenat Diagn. 1989. PMID: 2717533
Primary hyperoxaluria type 1 (PH1) is caused by a deficiency of the hepatic peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT, EC 2.6.1.44) (Danpure and Jennings, FEBS Lett., 201, 20-24, 1986). ...
Primary hyperoxaluria type 1 (PH1) is caused by a deficiency of the hepatic peroxisomal enzyme alanine: glyoxylate aminotransf …
The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.
Gough G, Heathers L, Puckett D, Westerhold C, Ren X, Yu Z, Crabb DW, Liangpunsakul S. Gough G, et al. Alcohol Clin Exp Res. 2015 Aug;39(8):1493-500. doi: 10.1111/acer.12780. Epub 2015 Jun 25. Alcohol Clin Exp Res. 2015. PMID: 26110815 Free PMC article.
The percentage of excessive drinkers with aspartate aminotransferase:alanine aminotransferase (AST:ALT) > 2 was only 2%, whereas 51% of subjects with alcoholic cirrhosis had AST:ALT > 2. ...Most subjects with excessive alcohol use do not have a h …
The percentage of excessive drinkers with aspartate aminotransferase:alanine aminotransferase (AST:ALT) > 2 was only 2 …
Four-year-old children with alpha 1-antitrypsin deficiency. Clinical follow-up and parental attitudes towards neonatal screening.
Sveger T, Thelin T. Sveger T, et al. Acta Paediatr Scand. 1981 Mar;70(2):171-7. doi: 10.1111/j.1651-2227.1981.tb05537.x. Acta Paediatr Scand. 1981. PMID: 6972148
The children with alpha 1 AT deficiency had the following Pi types: 118 PiZ, 50 PiSZ, 2 PiZ-, 1 PiS-, 1 PiFZ. ...Forty parents of children with alpha AT deficiency PiZ answered a questionnaire concerning their reaction to, knowledge about and attitudes toward …
The children with alpha 1 AT deficiency had the following Pi types: 118 PiZ, 50 PiSZ, 2 PiZ-, 1 PiS-, 1 PiFZ. ...Forty parents …
Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis.
Monico CG, Rossetti S, Schwanz HA, Olson JB, Lundquist PA, Dawson DB, Harris PC, Milliner DS. Monico CG, et al. J Am Soc Nephrol. 2007 Jun;18(6):1905-14. doi: 10.1681/ASN.2006111230. Epub 2007 Apr 25. J Am Soc Nephrol. 2007. PMID: 17460142
Mutations in AGXT, a locus mapped to 2q37.3, cause deficiency of liver-specific alanine:glyoxylate aminotransferase (AGT), the metabolic error in type 1 primary hyperoxaluria (PH1). ...A described frameshift mutation (c.33_34insC) occurred with the next highest freq …
Mutations in AGXT, a locus mapped to 2q37.3, cause deficiency of liver-specific alanine:glyoxylate aminotransferase (AGT), the …
Polymorphisms in the alanine:glyoxylate aminotransferase gene and their application to the prenatal diagnosis of primary hyperoxaluria type 1.
Rumsby G, Mandel H, Avey C, Geraerts A. Rumsby G, et al. Nephrol Dial Transplant. 1995;10 Suppl 8:30-2. doi: 10.1093/ndt/10.supp8.30. Nephrol Dial Transplant. 1995. PMID: 8592623
Primary hyperoxaluria type 1 (PH1) is caused by a deficiency of the hepatic alanine:glyoxylate aminotransferase enzyme encoded by the AGXT gene on chromosome 2. ...The remaining four families were only partially informative. Five additional linkage markers on …
Primary hyperoxaluria type 1 (PH1) is caused by a deficiency of the hepatic alanine:glyoxylate aminotransferase enzyme encoded …
15 results